Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 2024 Apr 18;73(6):105. doi: 10.1007/s00262-024-03668-8

Correction to: Dominant‑negative transforming growth factor‑β receptor‑armoured mesothelin‑targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer

Ke Li 1, Jing Xu 1, Jing Wang 1, Chong Lu 1, Yilin Dai 1, Qing Dai 2, Wang Zhang 2, Congjian Xu 1, Shu Wu 2,, Yu Kang 1,
PMCID: PMC11026349  PMID: 38634982

Correction to: Cancer Immunology, Immunotherapy (2023) 72:917–928 10.1007/s00262-022-03290-6

In the original version of this article, Ke Li and Jing Xu should have been denoted as equally contributing authors.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Shu Wu, Email: Simon.Wu@legendbiotech.com.

Yu Kang, Email: yukang@fudan.edu.cn.


Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES